Literature DB >> 22869465

Association of lower hemoglobin level and neuropathology in community-dwelling older persons.

Raj C Shah1, Julie A Schneider, Sue Leurgans, David A Bennett.   

Abstract

Lower hemoglobin levels have been associated with cognitive decline in older persons. The objective of this study was to investigate the relationship between lower hemoglobin levels and common, age-related neuropathologies associated with cognitive decline. Hemoglobin and neuropathology measures were available in 113 deceased, community-dwelling, older adults participating in the Rush Memory and Aging Project, a prospective, observational, clinical pathology study of aging. The mean hemoglobin level was 13.0 g/dL (SD = 1.4) and was measured 3.2 (SD = 1.3) years prior to death. Thirty-five participants had at least one chronic macroscopic infarction and twenty-nine had at least one chronic microscopic infarction. Eleven participants had Lewy Bodies. The mean Alzheimer's disease pathology score based on a summary measure of neuritic plaques, diffuse plaques, and neurofibrillary tangles was 0.56 unit (SD = 0.56; range = 0, 2.34). Using logistic regression models adjusted for age at death, gender, and education, each g/dL lower hemoglobin level increased the odds for having a chronic macroscopic infarction by 37% (95% CI = 1.01, 1.86) but not for having a chronic microscopic infarction (OR = 1.11; 95% CI = 0.82, 1.52) or Lewy Bodies (OR = 1.07; 95% CI = 0.68, 1.68). In an adjusted multiple regression model, hemoglobin level was not associated with the global AD pathology measure (parameter estimate = -0.02, SE = 0.03, p = 0.6). In secondary analyses, lower hemoglobin levels were associated with higher odds of having a chronic macroscopic infarction in a subcortical region but not with higher total subcortical chronic macroscopic infarction volume. In conclusion, lower hemoglobin levels appear to be associated with chronic macroscopic infarctions but not other common age-related neuropathologies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869465      PMCID: PMC3496930          DOI: 10.3233/JAD-2012-120952

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  44 in total

1.  The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

Authors:  M S Green; J A Kaye; M J Ball
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

2.  Neuropathology of older persons without cognitive impairment from two community-based studies.

Authors:  D A Bennett; J A Schneider; Z Arvanitakis; J F Kelly; N T Aggarwal; R C Shah; R S Wilson
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

3.  Relation of cerebral infarctions to dementia and cognitive function in older persons.

Authors:  J A Schneider; R S Wilson; E J Cochran; J L Bienias; S E Arnold; D A Evans; D A Bennett
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

4.  Impact of anemia on mortality, cognition, and function in community-dwelling elderly.

Authors:  Susan D Denny; Maragatha N Kuchibhatla; Harvey Jay Cohen
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

5.  Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study.

Authors:  Alessandro Ble; Jeffrey C Fink; Richard C Woodman; Mark A Klausner; B Gwen Windham; Jack M Guralnik; Luigi Ferrucci
Journal:  Arch Intern Med       Date:  2005-10-24

6.  Cognitive functioning as a predictor of functional disability in later life.

Authors:  Lisa C McGuire; Earl S Ford; Umed A Ajani
Journal:  Am J Geriatr Psychiatry       Date:  2006-01       Impact factor: 4.105

7.  Anaemia increases the risk of dementia in cognitively intact elderly.

Authors:  Anna Rita Atti; Katie Palmer; Stefano Volpato; Giovanni Zuliani; Bengt Winblad; Laura Fratiglioni
Journal:  Neurobiol Aging       Date:  2006-02       Impact factor: 4.673

8.  The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort.

Authors:  David A Bennett; Julie A Schneider; Aron S Buchman; Carlos Mendes de Leon; Julia L Bienias; Robert S Wilson
Journal:  Neuroepidemiology       Date:  2005-08-15       Impact factor: 3.282

Review 9.  Subcortical ischaemic vascular dementia.

Authors:  Gustavo C Román; Timo Erkinjuntti; Anders Wallin; Leonardo Pantoni; Helena C Chui
Journal:  Lancet Neurol       Date:  2002-11       Impact factor: 44.182

10.  Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study.

Authors:  Jerome L Abramson; Claudine T Jurkovitz; Viola Vaccarino; William S Weintraub; William McClellan
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

View more
  5 in total

1.  The red cell distribution width and anemia in association with prevalent dementia.

Authors:  Jennifer Weuve; Carlos F Mendes de Leon; David A Bennett; Xinqi Dong; Denis A Evans
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Apr-Jun       Impact factor: 2.703

Review 2.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease.

Authors:  Laura M Winchester; John Powell; Simon Lovestone; Alejo J Nevado-Holgado
Journal:  Genome Med       Date:  2018-06-28       Impact factor: 11.117

4.  Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI.

Authors:  Frank J Wolters; Hazel I Zonneveld; Silvan Licher; Lotte G M Cremers; M Kamran Ikram; Peter J Koudstaal; Meike W Vernooij; M Arfan Ikram
Journal:  Neurology       Date:  2019-07-31       Impact factor: 9.910

5.  Single-cell RNA sequencing reveals dysregulation of spinal cord cell types in a severe spinal muscular atrophy mouse model.

Authors:  Junjie Sun; Jiaying Qiu; Qiongxia Yang; Qianqian Ju; Ruobing Qu; Xu Wang; Liucheng Wu; Lingyan Xing
Journal:  PLoS Genet       Date:  2022-09-08       Impact factor: 6.020

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.